CSBR
Price
$5.07
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
70.98M
4 days until earnings call
Intraday BUY SELL Signals
MREO
Price
$0.28
Change
+$0.04 (+16.67%)
Updated
Sep 11 closing price
Capitalization
44.51M
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CSBR vs MREO

CSBR vs MREO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CSBR vs. MREO commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSBR is a StrongBuy and MREO is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSBR($71M) has a higher market cap than MREO($44.5M). CSBR YTD gains are higher at: -26.628 vs. MREO (-32.805). CSBR has higher annual earnings (EBITDA): -772K vs. MREO (-26.83M). MREO has more cash in the bank: 30.1M vs. CSBR (7.13M). MREO has less debt than CSBR: MREO (1.03M) vs CSBR (4.89M). CSBR has higher revenues than MREO: CSBR (57.9M) vs MREO (0).
CSBRMREOCSBR / MREO
Capitalization71M44.5M160%
EBITDA-772K-26.83M3%
Gain YTD-26.628-32.80581%
P/E Ratio35.88N/A-
Revenue57.9M0-
Total Cash7.13M30.1M24%
Total Debt4.89M1.03M475%
FUNDAMENTALS RATINGS
CSBR vs MREO: Fundamental Ratings
CSBR
MREO
OUTLOOK RATING
1..100
3610
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6387
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MREO's Valuation (61) in the null industry is in the same range as CSBR (87) in the Biotechnology industry. This means that MREO’s stock grew similarly to CSBR’s over the last 12 months.

MREO's Profit vs Risk Rating (100) in the null industry is in the same range as CSBR (100) in the Biotechnology industry. This means that MREO’s stock grew similarly to CSBR’s over the last 12 months.

MREO's SMR Rating (98) in the null industry is in the same range as CSBR (98) in the Biotechnology industry. This means that MREO’s stock grew similarly to CSBR’s over the last 12 months.

CSBR's Price Growth Rating (63) in the Biotechnology industry is in the same range as MREO (87) in the null industry. This means that CSBR’s stock grew similarly to MREO’s over the last 12 months.

MREO's P/E Growth Rating (2) in the null industry is in the same range as CSBR (8) in the Biotechnology industry. This means that MREO’s stock grew similarly to CSBR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSBRMREO
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
88%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CSBR: $5.07 vs. MREO: $0.28)
Brand notoriety: CSBR and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSBR: 151% vs. MREO: 184%
Market capitalization -- CSBR: $70.98M vs. MREO: $44.51M
CSBR [@Biotechnology] is valued at $70.98M. MREO’s [@Biotechnology] market capitalization is $44.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSBR’s FA Score shows that 1 FA rating(s) are green while MREO’s FA Score has 1 green FA rating(s).

  • CSBR’s FA Score: 1 green, 4 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, both CSBR and MREO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSBR’s TA Score shows that 5 TA indicator(s) are bullish while MREO’s TA Score has 5 bullish TA indicator(s).

  • CSBR’s TA Score: 5 bullish, 3 bearish.
  • MREO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CSBR is a better buy in the short-term than MREO.

Price Growth

CSBR (@Biotechnology) experienced а -2.87% price change this week, while MREO (@Biotechnology) price change was +12.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CSBR is expected to report earnings on Sep 16, 2026.

MREO is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CSBR
Daily Signal:
Gain/Loss:
MREO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRZIX13.480.10
+0.71%
BlackRock Sust Aware Adg Intl Eq Ins
DFREX44.240.28
+0.64%
DFA Real Estate Securities I
RSNRX69.83N/A
N/A
Victory Global Energy Transition A
PGOFX56.16N/A
N/A
Victory Pioneer Select Mid Cap Growth A
TNRAX22.85N/A
N/A
1290 Avantis U.S. Large Cap Growth A

CSBR and

Correlation & Price change

A.I.dvisor tells us that CSBR and CURX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBR and CURX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSBR
1D Price
Change %
CSBR100%
N/A
CURX - CSBR
29%
Poorly correlated
+0.68%
RADX - CSBR
27%
Poorly correlated
-3.88%
OABI - CSBR
25%
Poorly correlated
+3.04%
VTGN - CSBR
25%
Poorly correlated
-0.84%
MREO - CSBR
24%
Poorly correlated
+14.47%
More